(S)-tert-Butyl (3-hydroxy-3-methylbutan-2-yl)carbamate

Catalog No. :
ACPTBJ029
CAS No. :
449811-20-5
Molecular Formula :
C10H21NO3
Molecular Weight :
203.28

IUPAC Name:tert-butyl (S)-(3-hydroxy-3-methylbutan-2-yl)carbamate

(S)-tert-Butyl (3-hydroxy-3-methylbutan-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$50.00Login to see priceIn stockIn stock
1g95%$132.00Login to see priceIn stockIn stock
5g95%$458.00Login to see priceIn stockIn stock
25g95%$2058.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-tert-Butyl (3-hydroxy-3-methylbutan-2-yl)carbamate
IUPAC Nametert-butyl (S)-(3-hydroxy-3-methylbutan-2-yl)carbamate
MDL No.MFCD16996060
Molecular FormulaC10H21NO3
Molecular Weight203.28
SMILESO=C(OC(C)(C)C)N[C@H](C(C)(O)C)C
InChI KeyZBSFLGNSQZRBCS-ZETCQYMHSA-N
SynonymCarbamic acid, [(1S)-2-hydroxy-1,2-dimethylpropyl]-, 1,1-dimethylethyl ester;(S)-tert-butyl 3-hydroxy-3-methylbutan-2-ylcarbamate;Tert-butyl (s)-(3-hydroxy-3-methylbutan-2-yl)carbamate
CAS No.449811-20-5
PubChem CID45091995

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACPTBJ029 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXFTY914 route compound structure diagram
    ACXFTY91428875-17-4 In Stock
  2. Then
  3. ACPTBJ029 route product structure diagram
    ACPTBJ029449811-20-5 In Stock
Inquiry

2. ACPTBJ029 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXFTY914 route compound structure diagram
    ACXFTY91428875-17-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPTBJ029 route product structure diagram
    ACPTBJ029449811-20-5 In Stock
Inquiry

Comments (0)